Supplemental
Capital Expenditures Incurred but Not Yet Paid
Moderna Capital Expenditures Incurred but Not Yet Paid decreased by 14.6% to $35.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.0%, from $50.00M to $35.00M.
Analysis
StatementCash Flow Statement
SectionSupplemental
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Metric ID:
orcl_unpaid_capital_expendituresHistorical Data
13 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.00M | $21.00M | $45.00M | $64.00M | $31.00M | $98.00M | $7.00M | $43.00M | $91.00M | $19.00M | $50.00M | $41.00M | $35.00M |
| QoQ Change | — | -12.5% | +114.3% | +42.2% | -51.6% | +216.1% | -92.9% | +514.3% | +111.6% | -79.1% | +163.2% | -18.0% | -14.6% |
| YoY Change | — | — | — | — | +47.6% | +53.1% | — | +38.7% | -7.1% | — | -45.1% | +115.8% | -30.0% |
Range$7.00M – $98.00M
CAGR+13.4%
Avg YoY Growth+24.7%
Median YoY Growth+38.7%
Current Streak2 quarters decline
Capital Expenditures Incurred but Not Yet Paid at Other Companies
Frequently Asked Questions
- What is Moderna's capital expenditures incurred but not yet paid?
- Moderna (MRNA) reported capital expenditures incurred but not yet paid of $35.00M in Q1 2026.
- How has Moderna's capital expenditures incurred but not yet paid changed year-over-year?
- Moderna's capital expenditures incurred but not yet paid decreased by 30.0% year-over-year, from $50.00M to $35.00M.